Part 6/9:
The stigma of "pill mills" resurfaced with the advent of telehealth, especially following the pandemic, where restrictions on prescription protocols were relaxed. Some platforms aggressively marketed drugs like Adderall or testosterone, with patients essentially prescribing themselves through online forms. These practices raised alarms regarding the integrity of medical assessments in telehealth environments.
A notable case involved the company Dunn, which faced serious legal challenges due to allegations of reckless prescription practices. This case exemplifies a broader issue — the commercialization of health care services. As demand for medications surged during the pandemic, the telehealth industry exploded, but not without potential for harm.